Wednesday, September 10, 2003 10:39:22 AM
http://www.biomedcentral.com/news/20030909/04/
"So the team turned to other methods, such as mitochondrial DNA analysis, which is being performed by Celera Genomics, and single nucleotide polymorphism (SNP) analysis, which is being performed by Orchid Biosciences' GeneScreen."
However, this is utilizing SNP testing where traditional STR testing is not sufficient. At some stage, after concerted efforts with the various conventional testing approaches, there will still be a large number of unidentified DNA samples. I wonder whether DNAWitness might not be used for these to try to identify individuals based on ancestry and the other traits that are perhaps now available.
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM